Edesa Biotech Adds Mechanically Ventilated Patients to Phase 3 ARDS Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Edesa Biotech Adds Mechanically Ventilated Patients to Phase 3 ARDS Study
(NASDAQ: EDSA) Delayed: 5.80 +0.15 (2.65%)
Previous Close $5.65    52 Week High $ 
Open $5.65    52 Week Low $ 
Day High $6.27    P/E N/A 
Day Low $5.58    EPS $ 
Volume 174,849